Biologics Royal Biologics Announces U.S. Commercial Launch of BIOINCYTE™ PRFM byJosh SandbergFebruary 14, 2023
Biologics Regulatory Spine Sports Medicine Top Stories Royal Biologics Announces FDA 510K Approval and U.S. Commercial Launch of the MAXX™-BMC Bone Marrow Aspirate Concentration System byJosh SandbergJune 1, 2022
Biologics Top Stories Royal Biologics announces U.S. commercial launch of Advanced-Cell™, an advanced bone grafting and fusion convenience kit. byJosh SandbergApril 26, 2022
Biologics Regulatory Sports Medicine Top Stories Royal Biologics announces FDA Approval of the Maxx™ Concentration System. byJosh SandbergSeptember 7, 2021
Biologics Extremities Top Stories Royal Biologics Announces Partnership with Vilex to Distribute Their ALC Technology Portfolio for Expansion of Biologics in Lower Extremity Procedures byJosh SandbergAugust 17, 2021
Biologics Financial Hospitals Top Stories Royal Biologics Wound Care Portfolio Receives High-Tier Reimbursement byJosh SandbergFebruary 17, 2021
Biologics Extremities Top Stories Royal Biologics Announces the Launch of Fibri-Cell™, Live Cellular Cortical Fibers With Osteo-Spin™ Technology byChris StewartDecember 2, 2020
Biologics Extremities Royal Biologics Completes 100th Cryo Cord™ Case, Successfully Enrolls First Patient Into Diabetic Foot Ulcer Study byJosh SandbergSeptember 29, 2020
Biologics Top Stories Royal Biologics Announces the Acquisition of FIBRINET byChris StewartSeptember 3, 2020
